Why the study?
How do the risk profile and treatment patterns of diabetic patients with ACS in Saudi Arabia compare to an international cohort?
How do the risk profile and treatment patterns of diabetic patients with ACS in Saudi Arabia compare to an international cohort?
Diabetic patients with ACS in Saudi Arabia presented with lower risk profiles and had different medication utilization patterns compared to an international cohort, though demographic data were similar.
Answers are grounded in this paper and cite their sources.
Saudi diabetic ACS patients show lower-risk profiles than international cohorts; leaves open whether local risk models or outcomes differ.
Background Multicenter International Diabetes–Acute Coronary Syndromes (MIDAS) study aimed to monitor the adherence to evidence-based therapy among diabetic patients (DM) with unstable angina or non-ST-segment elevation myocardial infarction (ACS) and to describe the in-hospital outcomes of DM in the setting of ACS. We presente the data of Kingdom of Saudi Arabia (KSA) based on the risk profile of the patients in comparison to the international registry. Design Data of DM patients with ACS who presented at the time of admission to the emergency/coronary care units in 5 hospitals in KSA were extracted from the registry. A total of 3624 patients were enrolled in several countries in Europe and the Middle East and India. The following variables were extracted: ST deviation ⩾0.5 mm, positive troponin and, TIMI risk score. The Z test for two proportions was used to compare the KSA values with the international figures. Analysis was done using stata 10. Level of significance was set at 5%. Results “Type II: type I DM ratio” in KSA was comparable to the international ratio (93.65 vs. 93.83). The high risk factors were significantly less prevalent in KSA in comparison to the international Figs. (17% showed significant ST deviation ⩾0.5 mm vs 46%, ( p = 0.005), 40% showed positive troponin vs 70% ( p < 0.0001) and, 32% showed TIMI risk score >3 in comparison to 62% ( p < 0.0001). The utilization of GP IIb/IIIa was 18.3% in KSA vs. 37.4% internationally ( p = 0.046). On the contrary, the utilization of clopidogril/Ticlopidine was 96.8% in KSA vs. 74.7% internationally ( p < 0.0001). The percentage of early coronary angiography was 38.9% in KSA vs. 46.1% internationally ( p = 0.292). Among patients who had early coronary angiography, 34.9% had revascularization (PCI and/or CABG) in KSA in comparison to 54.8% in the international figures ( p = 0.199). Conclusions DM Saudi patients with ACS had similar demographic data to the international patients. There was a satisfactory use of evidence-based medicine in treatment in such group.
No takes yet. Share an insight, caveat, or question.
Kinsara et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: